Protein detail

OX2R

Orexin receptor type 2 (Ox-2-R) (Ox2-R) (Ox2R) (Hypocretin receptor type 2)

Entry name
OX2R
UniProt ID
EVMP score
0.50
Frequency
1
Transmembrane count
7
Protein classification
FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins
EVMP score: annotation confidence score.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information
Protein Names
Orexin receptor type 2 (Ox-2-R) (Ox2-R) (Ox2R) (Hypocretin receptor type 2)
Protein Class
FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins
Protein Function
  • FDA approved drug targets:Small molecule drugs
  • G-protein coupled receptors:GPCRs excl olfactory receptors
Transmembrane
55..75; Helical; Name=1; 89..110; Helical; Name=2; 128..150; Helical; Name=3; 171..191; Helical; Name=4; 223..243; Helical; Name=5; 305..326; Helical; Name=6; 343..366; Helical; Name=7
Transmembrane Count
7
Entrez Gene Symbol
Gene Synonym
ORXR2OX2ROXR2
Gene Description
Hypocretin receptor 2
Chromosome
6
Position
55106460-55282617
Frequency
1
EVMP Score
0.50
Fluorescence & Localization
Tissue Specificskin 1Cell SpecificBreast secretory cells
Function & Pathway
Relations & Evidence

Enzyme-Mediated Modification

0 records.

Ligand-Receptor Signaling

54 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
gpcrreceptorAlmen2009NoYesNoYesNo
rhodopsinreceptorAlmen2009NoYesNoYesNo
gpcrreceptorUniProt_keywordNoYesNoYesNo
seven_transmembrane_7tmreceptorHPMRNoYesNoYesNo
7tm_areceptorHPMRNoYesNoYesNo
neuropeptidey_tachykinin_orexin_pancreatic_peptide_7tm_areceptorHPMRNoYesNoYesNo
rhodopsinreceptorSurfaceomeNoYesNoYesNo
gpcrreceptorSurfaceomeNoYesNoYesNo
class_a_rhodopsinreceptorGPCRdbNoYesNoYesNo
class_a_rhodopsin_peptidereceptorGPCRdbNoYesNoYesNo
Page 2 of 6PreviousNext

Regulatory Interaction Network

8 records.

Source Protein SymbolSource UniProt IDTarget Protein SymbolTarget UniProt IDIs DirectedIs StimulationIs InhibitionDatabaseReferences
OREXO43612OX2RO43614YesYesNoiTALKGuide2Pharma_LRdbSIGNORHINTHPMR_talklrHPMRCellChatDBHPRD_LRdbtalklrscConnectHPRDRamilowski2015_Baccin2019Guide2Pharma_CellinkerWangRamilowski2015HPMR_LRdbCellPhoneDBGuide2Pharma_talklrHPRD_talklrBaccin2019CellinkerEMBRACEGuide2PharmaCellTalkDBFantom5_LRdbHPMR_CellinkerconnectomeDB2020LRdbconnectomeDB2020:12702704scConnect:12890892HINT:33547286LRdb:9491897connectomeDB2020:11162621Guide2Pharma:12606634scConnect:9491897HINT:9491897connectomeDB2020:12208495Cellinker:9491897LRdb:18599270Guide2Pharma:9491897connectomeDB2020:18599270LRdb:11162621Cellinker:12702704Baccin2019:12702704CellTalkDB:9491897Baccin2019:18599270scConnect:27237973Guide2Pharma:11162621Guide2Pharma:12702704Baccin2019:12208495Guide2Pharma:26582739Guide2Pharma:27237973LRdb:12208495SIGNOR:9491897connectomeDB2020:9491897Cellinker:11162621Guide2Pharma:18599270scConnect:10498827Guide2Pharma:12208495LRdb:12702704HPRD:9491897scConnect:11162621scConnect:12702704scConnect:18599270scConnect:12606634scConnect:12208495Guide2Pharma:10498827Cellinker:18599270Baccin2019:9491897Cellinker:12208495HPMR:9491897scConnect:26582739Baccin2019:11162621
OX2RO43614GNAI1P63096YesYesNoHINTSIGNORHINT:35614071SIGNOR:31160049
OX2RO43614GNA13Q14344YesYesNoSIGNORSIGNOR:31160049
OX2RO43614GNA14O95837YesYesNoSIGNORSIGNOR:31160049
OX2RO43614GNAOP09471YesYesNoSIGNORSIGNOR:31160049
OX2RO43614GNAQP50148YesYesNoSIGNORSIGNOR:31160049
OX2RO43614GNAZP19086YesYesNoSIGNORSIGNOR:31160049
OX2RO43614GNAI3P08754YesYesNoSIGNORSIGNOR:31160049

Protein Complex Composition

1 record.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
HCRTR2O436142PDBPDB:6tpj

Isolation & Detection Technology

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationSize Exclusion ChromatographyWestern blottingMass spectrometry [LTQ-FT Ultra]Mass spectrometry201767121618490724370293743707282937253066373036693732142637357686373690383754212137968711379810653811724938649419386647223869903938811625389637613904423339174921
Sequence, Structure & Domains

Sequences

Length
444
Mass
50,694
Sequence
MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW

3D Structural Models

Turn
252..254; 332..335
Helix
40..47; 54..81; 83..85; 88..106; 108..117; 123..156; 166..183; 185..190; 218..231; 233..251; 294..328; 339..367; 369..381
Beta Strand
158..160; 191..196; 199..202; 207..212; 215..217
3D Structure
Electron microscopy (4); X-ray crystallography (7)

Domain & Motif Annotations

Compositional Bias
1..10; Basic and acidic residues
Domain (CC)
The N-terminal region is required for orexin signaling.
Region
1..20; Disordered; 33..49; Required for response to orexin-A
Protein Families
G-protein coupled receptor 1 family
Sequence Similarities
Belongs to the G-protein coupled receptor 1 family.
Clinical Relevance
Disease Involvement
FDA approved drug targets
Biomarker
Phase 2; Approved; Phase 1
Drug Targets
FDA approved drug targets